Format

Send to

Choose Destination
See comment in PubMed Commons below
J Minim Invasive Gynecol. 2014 May-Jun;21(3):394-8. doi: 10.1016/j.jmig.2013.10.005. Epub 2013 Oct 23.

Laparoendoscopic single-site radical hysterectomy with pelvic lymphadenectomy: initial multi-institutional experience for treatment of invasive cervical cancer.

Author information

1
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: dboruta@partners.org.
2
Division of Minimally Invasive Gynecology, University of Perugia, St. Maria Hospital, Terni, Italy.
3
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts.
4
Division of Gynecologic Oncology, HIMA-San Pablo, Caguas, Puerto Rico; Division of Gynecologic Oncology, Cleveland Clinic, Cleveland, Ohio.
5
Division of Gynecologic Oncology, Catholic University of the Sacred Heart, Rome, Italy.
6
Division of Gynecologic Oncology, Johns Hopkins Hospital, Baltimore, Maryland.
7
Division of Gynecologic Oncology, Cleveland Clinic, Cleveland, Ohio.

Abstract

STUDY OBJECTIVE:

To describe the feasibility, safety, and outcomes of women with stage I cervical cancer treated with laparoendoscopic single-site surgery radical hysterectomy (LESS-RH).

DESIGN:

A retrospective descriptive study (Canadian Task Force classification III).

SETTING:

Multiple academic teaching hospitals.

PATIENTS:

Women with Fédération Internationale de Gynécologie et d'Obstétrique FIGO stage IA1 to IB1 cervical cancer.

INTERVENTIONS:

LESS-RH as the primary therapy for cervical cancer performed by a gynecologic oncologist with expertise in LESS. A multichannel, single-port access device; a flexible-tipped 5-mm laparoscope; and a multifunctional instrument were used in all cases. Clinicopathologic, surgical, and perioperative outcomes were analyzed.

MEASUREMENTS AND MAIN RESULTS:

Twenty-two women were identified in whom a LESS-RH was attempted; 20 (91%) successfully underwent the procedure, including 19 in whom pelvic lymphadenectomy (PLND) was completed. Of the 2 converted procedures, 1 patient underwent 2-port laparoscopy secondary to truncal obesity, and 1 patient underwent conversion to laparotomy secondary to external iliac vein laceration during PLND. The median age and body mass index were 46 years and 23.3 kg/m(2), respectively. The median number of pelvic lymph nodes removed was 22. One patient experienced an intraoperative complication, and no patient required reoperation. The margins of excision were negative. One patient with 2 positive pelvic nodes and 1 patient with microscopic parametrial disease received adjuvant chemosensitized radiation; 3 additional patients received adjuvant radiation therapy secondary to an intermediate risk for recurrence. After a median follow up of 11 months, no recurrences were detected.

CONCLUSION:

LESS-RH/PLND is feasible and safe for select patients with stage I cervical cancer. Larger studies are needed to confirm whether the increased technical difficulty of this procedure justifies its use in routine gynecologic oncology practice.

KEYWORDS:

Cervical cancer; Laparoendoscopic single-site surgery; Radical hysterectomy

PMID:
24161887
DOI:
10.1016/j.jmig.2013.10.005
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center